SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: r.edwards who wrote (49546)1/29/1999 3:19:00 PM
From: Troll  Respond to of 119973
 
AWEB hit 5....should run



To: r.edwards who wrote (49546)1/29/1999 3:20:00 PM
From: QuietWon  Respond to of 119973
 
IMCL targets/localizes the delivery of the drug ! IMCL has stem cells, too



To: r.edwards who wrote (49546)1/29/1999 3:21:00 PM
From: QuietWon  Read Replies (1) | Respond to of 119973
 
IMCL - head & neck cancer -tumors gone in 8-30 days; Onxx still in phase ii



To: r.edwards who wrote (49546)1/29/1999 3:24:00 PM
From: QuietWon  Respond to of 119973
 
IMCL - on 87% of patients it was completely effective in reducing tumors; on remaining 13% over 50% effective



To: r.edwards who wrote (49546)1/29/1999 3:26:00 PM
From: QuietWon  Read Replies (1) | Respond to of 119973
 
little onxx only 33% complete regression AND 8% HAD WORSE cancer - it grew!!



To: r.edwards who wrote (49546)1/29/1999 3:27:00 PM
From: QuietWon  Read Replies (1) | Respond to of 119973
 
on the FACTS, IMCL way ahead time wise; way better rate of cure; way better time of cure - whiuch is the better company??????????



To: r.edwards who wrote (49546)1/29/1999 3:57:00 PM
From: QuietWon  Respond to of 119973
 
IMCL way better therapy than onxx, imo, and FDA opinion re approval pending